Landec

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Lifecore, Curation Foods, and Others. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Maria, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It operates through the following business segments: Lifecore, Curation Foods, and Others. The Lifecore segment focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The Curation Foods segment is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. The Others segment is Corporate, which includes corporate general and administrative expenses, Non Lifecore and non-Curation Food interest income, interest expense, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Chaska, MN.

Cue Biopharma

Guaranty Bancshares

Harbor Custom Development, Inc.

Phillips 66

B. Riley Financial

Vector Group

Insider buying is often a profitable signal for bulls. Insiders only buy for one reason: they believe their company's stock is going higher.

7 Stocks With Insider Buying This Week Worth A Look

TreeHouse Foods

THS vs. LNDC: Which Stock Is the Better Value Option?

THS or LNDC: Which Is the Better Value Stock Right Now?

SANTA MARIA, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., announced today that Dr. Albert Bolles, the Company's President and Chief Executive Officer, and Jim Hall, Lifecore Biomedical's President, will be participating in a fireside chat to discuss Lifecore Biomedical's unique position as a specialty CDMO at the 23rd Annual ICR Virtual Conference during its Healthcare Day on Thursday, January 14, 2021, at 12:15 PM ET.

Landec Corporation to Participate in the 23rd Annual ICR Virtual Conference

Landec Corporation (LNDC) CEO Albert Bolles on Q2 2021 Results - Earnings Call Transcript

Landec (LNDC) delivered earnings and revenue surprises of -33.33% and -2.49%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

Landec (LNDC) Q2 Earnings and Revenues Lag Estimates

Shares of Landec (NASDAQ:LNDC) fell 2.4% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 112.50% over the past year to $0.02, which beat the estimate of $0.01.

Recap: Landec Q2 Earnings

Reiterates Fiscal 2021 Guidance Reiterates Fiscal 2021 Guidance

Landec Corporation Reports Second Quarter and First Half Fiscal Year 2021 Results

On Wednesday, January 06, Landec (NASDAQ:LNDC) will release its latest earnings report. Check out Benzinga's preview to understand the implications.

Earnings Preview: Landec

Landec (LNDC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Landec (LNDC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

SANTA MARIA, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., will hold a conference call on Wednesday, January 6, 2021 at 2 p.m. Pacific time to discuss its results for the fiscal second quarter 2021. Financial results will be reported for the 2021 fiscal second quarter ended November 29, 2020 after market close on January 6, 2021.

Landec Corporation Sets Second Quarter 2021 Earnings Conference Call for January 6, 2021 at 2 p.m. PT

Landec Corporation (LNDC) CEO Albert Bolles on Q1 2021 Results - Earnings Call Transcript

Shares of Landec (NASDAQ:LNDC) fell 10.17% after the company reported Q1 results. Quarterly Results Earnings per share increased 31.25% year over year to ($0.11), which were in line with the estimate of ($0.11).

Recap: Landec Q1 Earnings

Landec (NASDAQ: LNDC) will be releasing its next round of earnings this Tuesday, October 06. For all of the relevant information, here is your guide for Tuesday's Q1 earnings announcement.

Earnings Outlook for Landec

Landec (LNDC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SANTA MARIA, Calif., Sept.  15, 2020  (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., will hold a conference call on Tuesday, October 6, 2020 at 2 p.m. Pacific time to discuss its results for the first quarter 2021. Financial results will be reported for the 2021 fiscal first quarter and year ended August 30, 2020 after market close on October 6, 2020.

Landec Corporation Sets First Quarter 2021 Earnings Conference Call for October 6, 2020 at 2 p.m. PT

SANTA MARIA, Calif., Aug.  25, 2020  (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness Company with two operating businesses, Curation Foods, Inc. (“Curation Foods”) and Lifecore Biomedical, Inc. (“Lifecore”), announced today the entry into a definitive agreement to sell the Company’s Hanover manufacturing facility and related assets for an aggregate purchase price of $8.7 million. The Company intends to consolidate its Hanover facility operations into its facilities in Guadalupe, California and Bowling Green, Ohio.

Landec Continues Progression of Transformation Plan for Curation Foods, Announcing Agreement to Divest Hanover Manufacturing Operations

Landec Corporation (LNDC) CEO Albert Bolles on Q4 2020 Results - Earnings Call Transcript

Landec (LNDC) delivered earnings and revenue surprises of 66.67% and 0.02%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?

Landec (LNDC) Q4 Earnings and Revenues Top Estimates

Shares of Landec (NASDAQ:LNDC) were unchanged after the company reported Q4 results.

Recap: Landec Q4 Earnings

Provides Fiscal 2021 Outlook Provides Fiscal 2021 Outlook

Landec Corporation Reports Fourth Quarter and Full Year 2020 Results

Landec (LNDC) Earnings Expected to Grow: Should You Buy?

SANTA MARIA, Calif., July  21, 2020  (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., will hold a conference call on Tuesday, August 11, 2020 at 2 p.m. Pacific time to discuss its results for the fourth quarter and fiscal year 2020. Financial results will be reported for the 2020 fiscal fourth quarter and year ended May 31, 2020 after market close on August 11, 2020.

Landec Corporation Sets Fourth Quarter and Fiscal Year 2020 Earnings Conference Call for August 11, 2020 at 2 p.m. PT

SANTA CLARA, Calif., July  16, 2020  (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (the “Company”), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., today announced its entry into an amendment to its credit agreement with its syndicate of lenders on July 15, 2020.

Landec Corporation Amends Credit Agreement

Special conference call scheduled for Monday, June 29, 2020 at 5 p.m. Eastern Time Special conference call scheduled for Monday, June 29, 2020 at 5 p.m. Eastern Time

Landec Corporation Provides Update on Curation Foods Transformation and Announces Preliminary Fiscal 2020 Fourth Quarter Results

McCormick

LNDC vs. MKC: Which Stock Is the Better Value Option?

News for Landec Stock (LNDC)